153243-59-5Relevant academic research and scientific papers
CARBOXYOIC ACID COMPOUNDS AND DRUGS CONTAINING THE COMPOUNDS AS THE ACTIVE INGREDIENT
-
Page 72-73, (2010/02/09)
A carboxylic acid compound represented by formula (I): (meanings of the symbols in the formula are as mentioned in the specification) and a pharmaceutical agent comprising the compound. Since the compound represented by formula (I) binds to a DP receptor and shows antagonistic activity for the DP receptor, it is useful for prevention and/or treatment of diseases such as allergic disease (such as allergic rhinitis, allergic conjunctivitis, atopic dermatitis, bronchial asthma and food allergy), systemic mastocytosis, disorders accompanied by systemic mast cell activation, anaphylaxis shock, bronchoconstriction, urticaria, eczema, diseases accompanied by itch (such as atopic dermatitis and urticaria), diseases (such as cataract, retinal detachment, inflammation, infection and sleeping disorders) which is generated secondarily as a result of behavior accompanied by itch (such as scratching and beating), inflammation, chronic obstructive pulmonary diseases, ischemic reperfusion injury, cerebrovascular accident, chronic rheumatoid arthritis, pleurisy, ulcerative colitis and the like.
N-acylpyrrolidines and medicaments for the treatment or prevention of disorders linked to CKK and to gastrin
-
, (2008/06/13)
The present invention relates to derivatives of formula: STR1 to their salts, to their preparation and to the medicaments containing them.
Pyrrolidine and thiazolidine derivatives, their preparation and medicaments containing them
-
, (2008/06/13)
This invention relates to compositions of formula: STR1 and their salts, their preparation and the medicaments containing them.
